Tumour mutational burden analysis: implementation in routine diagnostics (2019) Kroeze L, Kamping E, Von Rhein D, Jansen E, De Voer R, Barberis M, Botling J, et al. Conference contribution Large nested variant of urothelial carcinoma: a prime example of a FGFR3-mutated, luminal tumour (2019) Weyerer V, Eckstein M, Comperat E, Juette H, Allory Y, Stoehr R, Wullich B, et al. Conference contribution Tumour immune microenvironment drives prognostic relevance correlating with bladder cancer subtypes (2019) Eckstein M, Strissel P, Pfannstiel C, Chiappinelli K, Sikic D, Wach S, Taubert H, et al. Conference contribution MUC4 as a potential marker for differentiating MASC and PLGA in minor salivary glands (2019) Taverna C, Franchi A, Santucci M, Baneckova M, Skalova A, Agaimy A Conference contribution Glomerular disease associated with myeloproliferative and myelodysplastic/myeloproliferative neoplams (2019) Büttner-Herold M, Sticht C, Wiech T, Porubsky S Conference contribution Frequency of GNAS mutation in intramuscular myxoma (2019) Erber R, Stöhr R, Haller F, Hartmann A, Agaimy A Conference contribution Immunohistochemical TP53 expression in atypical fibroxanthoma and their mimics (2019) Erber R, Hartmann A, Agaimy A Conference contribution Challenging the prognostic impact of the new WHO and TNM classifications with special emphasis on HPV status in penile carcinoma (2019) Hölters S, Khalmurzaev O, Pryalukhin A, Loertzer P, Janssen M, Heinzelbecker J, Ueberdiek S, et al. Journal article Analysis of the prognostic relevance of sex-steroid hormonal receptor mRNA expression in muscle-invasive urothelial carcinoma of the urinary bladder (2019) Erben P, Sikic D, Wirtz RM, Martini T, Weis CA, Breyer J, Otto W, et al. Journal article Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme (2019) Ohashi R, Martignoni G, Hartmann A, Caliò A, Segala D, Stöhr C, Wach S, et al. Journal article